Published in J Biol Chem on July 23, 1999
Parameter estimate of signal transduction pathways. BMC Neurosci (2006) 0.89
Quantitative proteomics reveals dynamic interaction of c-Jun N-terminal kinase (JNK) with RNA transport granule proteins splicing factor proline- and glutamine-rich (Sfpq) and non-POU domain-containing octamer-binding protein (Nono) during neuronal differentiation. Mol Cell Proteomics (2014) 0.82
Bone marrow-derived fibroblast growth factor-2 induces glial cell proliferation in the regenerating peripheral nervous system. Mol Neurodegener (2012) 0.80
NGF-induced cell differentiation and gene activation is mediated by integrative nuclear FGFR1 signaling (INFS). PLoS One (2013) 0.78
NEAP/DUSP26 suppresses receptor tyrosine kinases and regulates neuronal development in zebrafish. Sci Rep (2017) 0.75
VEGF(165) mediates glomerular endothelial repair. J Clin Invest (1999) 2.18
Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry (1996) 1.91
Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev (1996) 1.82
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo. Cancer Res (2001) 1.56
Low concentrations of tetramethylammonium chloride increase yield and specificity of PCR. Nucleic Acids Res (1995) 1.52
The mitogenic signaling pathway of fibroblast growth factor is not mediated through polyphosphoinositide hydrolysis and protein kinase C activation in hamster fibroblasts. J Biol Chem (1986) 1.46
Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet (2000) 1.42
Modulation of cranial bone healing with a heparin-like dextran derivative. J Craniofac Surg (1996) 1.38
The use of acetone precipitation in the isolation of ribosomal proteins. Eur J Biochem (1976) 1.38
Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc Natl Acad Sci U S A (1990) 1.37
HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene (2008) 1.34
gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model. Proc Natl Acad Sci U S A (1982) 1.27
Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc Natl Acad Sci U S A (1989) 1.27
Bovine retina contains three growth factor activities with different affinity to heparin: eye derived growth factor I, II, III. Biochimie (1985) 1.24
Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Cancer Res (2001) 1.21
The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression. Oncogene (2012) 1.21
MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res (1991) 1.19
The endogenous oxindoles 5-hydroxyoxindole and isatin are antiproliferative and proapoptotic. Biochem Biophys Res Commun (2000) 1.14
Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood (1999) 1.09
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood (1998) 1.08
Purification, characterization, and biological properties of the eye-derived growth factor from retina: analogies with brain-derived growth factor. J Neurosci Res (1982) 1.06
Intimal hyperplasia recurs after removal of PDGF-AB and -BB inhibition in the rat carotid artery injury model. Arterioscler Thromb Vasc Biol (2000) 1.06
Specific fixation of bovine brain and retinal acidic and basic fibroblast growth factors to mouse embryonic eye basement membranes. Exp Cell Res (1987) 1.05
Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. Biochem Biophys Res Commun (1991) 1.04
Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res (2001) 1.02
Telomeres inhibit end to end fusion and enhance maintenance of linear DNA molecules injected into the Paramecium primaurelia macronucleus. Nucleic Acids Res (1991) 1.01
Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors (1994) 1.01
Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro. In Vitro Cell Dev Biol Anim (1999) 1.00
Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol (2001) 0.96
Evidence and characterization of the receptor to eye-derived growth factor I, the retinal form of basic fibroblast growth factor, on bovine epithelial lens cells. Proc Natl Acad Sci U S A (1986) 0.95
Sequence and analysis of chromosome I of the amitochondriate intracellular parasite Encephalitozoon cuniculi (Microspora). Genome Res (2001) 0.93
[Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy]. J Fr Ophtalmol (2008) 0.92
Immunological study of acidic fibroblast growth factor (aFGF) distribution in the eye. J Cell Biochem (1989) 0.91
Involvement of heparin affin regulatory peptide in human prostate cancer. Prostate (1999) 0.91
Early and late mitogenic events induced by FGF on bovine epithelial lens cells are not triggered by hydrolysis of polyphosphoinositides. Biochem Biophys Res Commun (1987) 0.91
Phenotypic modulations of human umbilical vein endothelial cells and human dermal fibroblasts using two angiogenic assays. Biol Cell (1991) 0.90
RNA-dependent DNA polymerase activity in Paramecium tetraurelia: what for? Eur J Biochem (1987) 0.90
Is there a ubiquitous growth factor in the eye? Proliferation induced in different cell types by eye-derived growth factors. Differentiation (1981) 0.90
Interactions of FGFs with target cells. Prog Growth Factor Res (1992) 0.90
Eye-derived growth factor isolated from bovine retina and used for epidermal wound healing in vivo. J Invest Dermatol (1986) 0.90
Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma. Urol Res (1992) 0.90
Human plasmin enzymatic activity is inhibited by chemically modified dextrans. J Biol Chem (2000) 0.89
Matrix therapy in regenerative medicine, a new approach to chronic wound healing. J Biomed Mater Res A (2009) 0.89
Target molecules for anti-angiogenic therapy: from basic research to clinical trials. Crit Rev Oncol Hematol (2000) 0.89
Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF. J Cell Physiol (1992) 0.89
Aptamers as reagents for high-throughput screening. Biotechniques (2001) 0.89
Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide. J Cell Physiol (1995) 0.88
The role of fibroblast growth factor-2 (FGF-2) in hematopoiesis. Prog Growth Factor Res (1995) 0.88
Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. J Biol Chem (1996) 0.88
Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression. J Biomed Mater Res (1999) 0.87
Modulation of the shape of epithelial lens cells in vitro directed by a retinal extract factor. A model of interconversions and the role of actin filaments and fibronectin. Differentiation (1981) 0.87
Recent developments in tumor angiogenesis. Curr Pharm Biotechnol (2007) 0.87
Neural and angiogenic defects in eyes of transgenic mice expressing a dominant-negative FGF receptor in the pigmented cells. Exp Eye Res (2000) 0.87
A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2. FASEB J (2001) 0.86
RGTA OTR4120, a heparan sulfate mimetic, is a possible long-term active agent to heal burned skin. J Biomed Mater Res A (2007) 0.86
Evidence for FGF-like growth factor in adult bovine retina: analogies with EDGF I. Biochem Biophys Res Commun (1986) 0.86
The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A. BMC Med (2010) 0.86
Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J Urol (1993) 0.86
Platelet releasate treatment improves skin healing in diabetic rats through endogenous growth factor secretion. Cell Mol Biol (Noisy-le-grand) (1998) 0.84
Identification of neighbouring proteins in Escherichia coli 30 S ribosome subunits. J Mol Biol (1977) 0.84
A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscle. FASEB J (1999) 0.84
Close proximity of Escherichia coli 50 S subunit proteins L7/L12 and L10 and L11. J Mol Biol (1976) 0.84
Heparin-like polymers derived from dextran enhance colonic anastomosis resistance to leakage. J Biomed Mater Res (1996) 0.83
Fibroblast growth factor-2 has opposite effects on human breast cancer MCF-7 cell growth depending on the activation level of the mitogen-activated protein kinase pathway. Eur J Biochem (1998) 0.83
Gamma heavy chain disease in man: translation and partial purification of mRNA coding for the deleted protein. Proc Natl Acad Sci U S A (1978) 0.83
Enhanced MYCN oncogene expression in human neuroblastoma cells is associated with altered FGF receptor expression and cellular growth response to basic FGF. Biochem Biophys Res Commun (1991) 0.83
A new approach to treat tissue destruction in periodontitis with chemically modified dextran polymers. FASEB J (2003) 0.82
RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats. Growth Factors (1998) 0.82
Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels. Oncogene (2008) 0.82
Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents. Gut (2004) 0.82
FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives. Int J Biol Macromol (1996) 0.82
Biochemical comparative studies between eye- and brain-derived growth factors. Biochimie (1987) 0.82
Heparan-like molecules induce the repair of skull defects. Bone (1995) 0.82
Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activity. J Biol Chem (2001) 0.82
Comparison of the effects of EGF, pFGF and EDGF on corneal epithelium wound healing. Curr Eye Res (1984) 0.82
RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies. J Fr Ophtalmol (2013) 0.81
Differential expression of FGF receptors and of myogenic regulatory factors in primary cultures of satellite cells originating from fast (EDL) and slow (Soleus) twitch rat muscles. Cell Mol Biol (Noisy-le-grand) (2000) 0.81
The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities. J Biol Chem (2001) 0.81
Identification of neighbouring proteins in E. coli 50S ribosomes. FEBS Lett (1975) 0.81
Functional Rac-1 and Nck signaling networks are required for FGF-2-induced DNA synthesis in MCF-7 cells. Oncogene (1999) 0.81
Identification of neighbouring proteins in the 30 S ribosomes of E. coli. FEBS Lett (1975) 0.81
The angiogenic factor heparin affin regulatory peptide (HARP) induces proliferation of human peripheral blood mononuclear cells. Cell Mol Biol (Noisy-le-grand) (2001) 0.81
Growth in serum-free medium of NIH3T3 cells transformed by the EJ-H-ras oncogene: evidence for multiple autocrine growth factors. Int J Cancer (1992) 0.80
Development and testing of radio and enzyme immunoassays for acidic fibroblast growth factor (aFGF). Anal Biochem (1988) 0.80
Proliferating satellite cells express acidic fibroblast growth factor during in vitro myogenesis. Dev Biol (1990) 0.80
Connexin 30, a new marker of hyperproliferative epidermis. Br J Dermatol (2006) 0.80
Thrombin mitogenic responses and protein phosphorylation are different in cultured human endothelial cells derived from large and microvessels. Exp Cell Res (1989) 0.80
Bioactive functionalized polymer of malic acid for bone repair and muscle regeneration. J Biomater Sci Polym Ed (2000) 0.80
Specific RGTA increases collagen V expression by cultured aortic smooth muscle cells via activation and protection of transforming growth factor-beta1. Matrix Biol (2001) 0.80
In vivo and in vitro studies of angiogenin--a potent angiogenic factor. Blood Coagul Fibrinolysis (1990) 0.80
Transmural endothelialization of vascular prostheses is regulated in vitro by Fibroblast Growth Factor 2 and heparan-like molecule. Int J Artif Organs (1997) 0.80
CXCL4L1-fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasis. Microvasc Res (2013) 0.80
Heparan mimetic regulates collagen expression and TGF-beta1 distribution in gamma-irradiated human intestinal smooth muscle cells. FASEB J (2001) 0.80
A highly reliable and sensitive assay for the purification of cellular growth factors. Cell Mol Biol (1984) 0.80
Glycosaminoglycans promote HARP/PTN dimerization. Biochem Biophys Res Commun (1999) 0.80
Studies on FGF-2: nuclear localization and function of high molecular weight forms and receptor binding in the absence of heparin. Mol Reprod Dev (1994) 0.79
Mesoglycan and sulodexide act as stabilizers and protectors of fibroblast growth factors (FGFs). Growth Factors (1994) 0.79